Streptococcal pharyngitis therapy. A comparison of two erythromycin formulations

Area of Science:

• Pediatric infectious diseases
• Pharmacology and pharmacokinetics
• Microbiology

Background:

• Streptococcal pharyngitis is a common childhood infection requiring effective antibiotic treatment.
• Current guidelines recommend 30-40 mg/kg/day of erythromycin for children.
• Previous studies suggested efficacy of lower-dose erythromycin estolate.

Purpose of the Study:

• To compare the efficacy of a lower dose of erythromycin estolate with a standard dose of erythromycin ethylsuccinate in treating pediatric streptococcal pharyngitis.
• To evaluate the impact of formulation on erythromycin efficacy and dosing in children.

Main Methods:

• An extension study comparing two treatment groups.
• Group 1: Erythromycin estolate at 20 mg/kg/day.
• Group 2: Erythromycin ethylsuccinate at 40 mg/kg/day.

Main Results:

• Nearly identical streptococcal eradication rates were observed between the two groups.
• Erythromycin estolate demonstrated efficacy at a lower dosage than recommended.
• Pharmacologic factors, including better absorption and higher serum/tissue levels, likely explain the efficacy of erythromycin estolate.

Conclusions:

• Erythromycin estolate is effective at 20 mg/kg/day for pediatric streptococcal pharyngitis.
• Dosage calculations for erythromycin should consider the specific formulation administered.
• Formulation-specific pharmacokinetics influence treatment efficacy in children.